These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29070437)
21. Analysis of Apoptotic, Clinical, and Laboratory Parameters in Type 1 Diabetes and Early Diabetic Nephropathy: Clustering and Potential Groups Evaluation for Additional Therapeutic Interventions. Burlaka I J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):313-323. PubMed ID: 35633645 [TBL] [Abstract][Full Text] [Related]
22. [Post-exercise microalbuminuria in newly diagnosed type 1 diabetic children - preliminary report]. Zmysłowska A; Młynarski W; Wegner O; Misiak G; Szadkowska A; Bodalski J Med Wieku Rozwoj; 2007; 11(2 Pt 1):139-43. PubMed ID: 17625283 [TBL] [Abstract][Full Text] [Related]
23. The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type. Mottl AK; Divers J; Dabelea D; Maahs DM; Dolan L; Pettitt D; Marcovina S; Imperatore G; Pihoker C; Mauer M; Mayer-Davis EJ; Pediatr Nephrol; 2016 Jun; 31(6):933-40. PubMed ID: 26754041 [TBL] [Abstract][Full Text] [Related]
25. [Related factors for microalbuminuria in adult type 1 diabetes patients of short disease duration]. Zheng XY; Luo SH; Wei XY; Ling P; Ai HY; Liu ZY; Lin QY; Lü J; Yao B; Yan JH; Weng JP; Yang DZ Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(6):419-423. PubMed ID: 32146763 [No Abstract] [Full Text] [Related]
26. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. Chae HW; Shin JI; Kwon AR; Kim HS; Kim DH J Korean Med Sci; 2012 Jul; 27(7):784-7. PubMed ID: 22787375 [TBL] [Abstract][Full Text] [Related]
27. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064 [TBL] [Abstract][Full Text] [Related]
28. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus. Wang N; Xu Z; Han P; Li T Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245 [TBL] [Abstract][Full Text] [Related]
29. Practical aspects of measuring microalbuminuria in diabetic patients. Jermendy G; Farkas K; Nádas J; Daróczy A; Péterfai E Diabetes Nutr Metab; 2001 Aug; 14(4):195-200. PubMed ID: 11716288 [TBL] [Abstract][Full Text] [Related]
30. Urinary biomarkers NG AL and beta-2 microglobulin in children with type 1 diabetes mellitus. Sachan N; Dabas A; Mantan M; Dabla PK J Pediatr Endocrinol Metab; 2024 Sep; 37(9):764-772. PubMed ID: 39166792 [TBL] [Abstract][Full Text] [Related]
31. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152 [TBL] [Abstract][Full Text] [Related]
32. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. Karavanaki K; Baum JD J Pediatr Endocrinol Metab; 2003 Jan; 16(1):79-90. PubMed ID: 12585344 [TBL] [Abstract][Full Text] [Related]
33. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study). Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298 [TBL] [Abstract][Full Text] [Related]
34. Screening of diabetic patients for microalbuminuria in primary care--The PROSIT-Project. Proteinuria Screening and Intervention. Piehlmeier W; Renner R; Schramm W; Kimmerling T; Garbe S; Proetzsch R; Fahn J; Piwernetz K; Landgraf R Exp Clin Endocrinol Diabetes; 1999; 107(4):244-51. PubMed ID: 10433063 [TBL] [Abstract][Full Text] [Related]
35. Microalbuminuria and Traditional Serum Biomarkers of Nephropathy among Diabetic Patients at Mbarara Regional Referral Hospital in South Western Uganda. Kiconco R; Rugera SP; Kiwanuka GN J Diabetes Res; 2019; 2019():3534260. PubMed ID: 31934589 [TBL] [Abstract][Full Text] [Related]
36. Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Bojestig M; Arnqvist HJ; Karlberg BE; Ludvigsson J Diabetes Care; 1996 Apr; 19(4):313-7. PubMed ID: 8729152 [TBL] [Abstract][Full Text] [Related]
38. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. Torffvit O; Agardh CD J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324 [TBL] [Abstract][Full Text] [Related]
39. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes. Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858 [TBL] [Abstract][Full Text] [Related]
40. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. Lampropoulou IT; Stangou M; Papagianni A; Didangelos T; Iliadis F; Efstratiadis G J Diabetes Res; 2014; 2014():394206. PubMed ID: 25587544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]